In the BioHarmony Drug Report Database
Imipramine
Janimine, Presamine, Tofranil (imipramine) is a small molecule pharmaceutical. Imipramine was first approved as Janimine on 1982-01-01. It is used to treat attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain, and panic disorder amongst others in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target muscarinic acetylcholine receptor M2, potassium voltage-gated channel subfamily H member 1, G protein-activated inward rectifier potassium channel 2, and G protein-activated inward rectifier potassium channel 4.
Trade Name
|
Janimine, Presamine, Tofranil |
|---|---|
Common Name
|
imipramine |
ChEMBL ID
|
CHEMBL11 |
Indication
|
attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain, panic disorder, psychotic affective disorders |
Drug Class
|
Antidepressants (imipramine type) |
Image (chem structure or protein)